News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Jef Akst | Sep 25, 2015
While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.
New Scripps Research Institute Leadership
Jef Akst | Sep 20, 2015
The nonprofit institution names a new CEO and president.
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Celladon Shutters Its R&D
Kerry Grens | Jun 26, 2015
Biotech firm likely to pull the plug after its gene therapy product fails.
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Roche Snags Tumor Tester for $1B
Kerry Grens | Jan 13, 2015
The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.
SAIC Founder Dies
Kerry Grens | Dec 30, 2014
J. Robert Beyster, who established one of the largest research and engineering firms, passed away at age 90.
Merck Buys Sigma-Aldrich for $17B
Kerry Grens | Sep 22, 2014
Two giants merge as the German drug maker acquires the US-based science supply company.
Keeping Up with IP
Kate Yandell | Aug 31, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Roche Buys Biotech for $8.3B
Jef Akst | Aug 27, 2014
The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.